Stay updated with breaking news from Combination Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Faron Pharmaceuticals Ltd. ("Faron" or "Company") Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II...
Investegate announcements from Faron Pharma. Oy, FDA and FIMEA approve BEXMAB study to begin
Search jobs Precigen Provides Latest Clinical Developments at Virtual R&D Update Event GERMANTOWN, Md., Dec. 15, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today held an R&D virtual event to provide an update on the latest progress for its clinical pipeline. The event showcased data from several of Precigen's most advanced clinical programs—PRGN-3005 UltraCAR-T®, PRGN-3006 UltraCAR-T® and AG019 ActoBiotics TM with presentat...